Bill Reveal
Back to All Bills
View on Congress.gov
H.R. 1492Passed 1 ChamberSector HeadwindHealth

Cracks Down on Prescription Drug 'Middlemen' (PBMs) & Bans Hidden Price Markups

Stops Pharmacy Benefit Managers from pocketing secret drug rebates and overcharging patients at the pharmacy counter.

Official Congressional Title (Patients Before Middlemen (PBM) Transparency & Reform Act)

To amend the Public Health Service Act and title XVIII of the Social Security Act to prohibit pharmacy benefit managers from engaging in spread pricing, mandate 100 percent rebate pass-through to health plans and patients, and delink PBM compensation from prescription drug list prices.

Sponsor:Rep. Buddy Carter (R-GA)
Cosponsors (88 total):
42 Dem•46 Rep
Bipartisan Consensus Score94/100
Legislative Status Tracker (Latest Action: 2026-10-15)
Introduced
In Committee
Passed 1 Chamber
Passed Both
Signed into Law

Latest: Passed House with bipartisan support; placed on Senate Legislative Calendar.

The Plain-English Breakdown

When you buy medicine at the pharmacy, there's a giant invisible middleman called a 'PBM' (Pharmacy Benefit Manager) sitting between the drug company, your insurance, and your local pharmacy. Three giant companies control 80% of all prescriptions in America. Because PBMs get paid a percentage of a drug's sticker price, they actually make MORE money when drug prices are higher! They also sometimes pay a local pharmacy $15 for a generic pill, bill your state health plan $60, and pocket the $45 difference ('spread pricing'). This bipartisan bill bans that markup trick and forces PBMs to charge a simple flat fee instead of taking percentage kickbacks on expensive drugs.

What Actually Changes in Real Life If Passed

  • Calculates your pharmacy co-pay based on the REAL discounted price of the medicine, not the inflated fake 'list price'.
  • Bans PBMs from charging Medicaid more for a prescription than they actually pay the pharmacist ('spread pricing').
  • Stops PBMs from paying rural and independent pharmacies below wholesale cost to force them out of business.
  • Eliminates the perverse incentive where middlemen prefer a $1,000 brand-name drug over a $30 generic because the $1,000 drug pays a bigger rebate.

Clause-by-Clause: Official Verbiage vs. Plain English

Side-by-side translation of the bill's key statutory sections

Sec. 101 — Delinking PBM Pay from Drug Sticker PricesFee Reform
📜 Official Statutory Verbiage

“A pharmacy benefit manager shall not receive any remuneration other than a bona fide flat-dollar service fee that does not vary based on the wholesale acquisition cost or list price.”

✨ Plain-English Translation

Middlemen can only charge a flat service fee—they can no longer take a percentage cut that rewards them when drug prices go up.

Sec. 202 — Nationwide Ban on Medicaid Spread PricingTaxpayer Savings
📜 Official Statutory Verbiage

“Payment for covered outpatient drugs under a State plan shall be based solely on the ingredient cost actually paid to the dispensing pharmacy plus a professional dispensing fee.”

✨ Plain-English Translation

PBMs cannot pay a pharmacy $10 for a pill, charge taxpayers $50, and secretly keep the $40 spread.

Who Wins / Benefits

Patients Paying High Co-Insurance & Independent Pharmacies

Lower out-of-pocket costs at the pharmacy counter and fairer reimbursement rates for neighborhood pharmacies.

Federal & State Taxpayers (CBO Scored Savings)

Saves an estimated $5B–$8B over 10 years in Medicare and Medicaid prescription drug spending.

Who Pays / Loses

The 'Big Three' PBMs (CVS Health, Cigna/Express Scripts, UnitedHealth/Optum)

Directly compresses high-margin PBM rebate retention and spread-pricing profit pools.

Market & Public Equity Impact

Sectors, ETFs, and public companies exposed to this legislation

Sector Headwind

Direct structural headwind for vertically integrated insurer-PBM conglomerates (CVS, CI, UNH); supportive for independent pharmacies and biosimilar adoption.

CVSCVS Health Corp (Caremark)
NEGATIVE

Operates Caremark, one of the top 3 U.S. PBMs; delinking and spread-pricing bans pressure PBM operating margins.

CIThe Cigna Group (Express Scripts)
NEGATIVE

Evernorth/Express Scripts unit faces margin compression from mandatory flat-fee compensation in Medicare Part D.

UNHUnitedHealth Group (OptumRx)
NEGATIVE

OptumRx PBM division faces tighter audit transparency and rebate pass-through mandates.

Rider & Hidden Pork Detector

Checks for unrelated attachments, earmarks, or omnibus logrolling

Rider Complexity10/100

Highly focused healthcare pricing reform bill that actually REDUCES the federal deficit according to CBO.